What can your patients gain with Serostim®?
Serostim® is indicated for the treatment of HIV patients with wasting or cachexia to increase lean body mass and body weight and improve physical endurance. Concomitant antiretroviral therapy is necessary.1
What can your patients gain with Serostim®?
Serostim® is indicated for the treatment of HIV patients with wasting or cachexia to increase lean body mass and body weight and improve physical endurance. Concomitant antiretroviral therapy is necessary.1
Serostim® improves 3 key symptoms of HIV-associated wasting
Serostim® is the only FDA-approved treatment proven to increase weight and lean body mass (LBM), as well as improve physical endurance. For over 20 years, Serostim® has been prescribed to treat patients with HIV-associated wasting. Concomitant antiretroviral therapy is necessary.1,2
In clinical trials, Serostim® significantly increased physical endurance, LBM, and weight2
One study was a 12-week, double-blind, placebo-controlled study in which 757 patients with HIV-associated wasting or cachexia were given Serostim® 0.1 mg/kg taken every day, Serostim® 0.1 mg/kg taken every other day, or a placebo.
Important resources for you
Download these documents to get your patients started on Serostim®
Show References
Hide References
- Serostim® (somatropin) [prescribing Information]. Rockland, MA: EMD Serono, Inc; 2018.
- Moyle GJ, Daar ES, Gertner JM, et al. Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2004;35(4):367-375.